|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
172557974X |
| 003 |
DE-627 |
| 005 |
20240817110932.0 |
| 007 |
tu |
| 008 |
200727s2017 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)172557974X
|
| 035 |
|
|
|a (DE-599)KXP172557974X
|
| 035 |
|
|
|a (OCoLC)1195490777
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
|
|a 616.079
|q DE-101
|
| 082 |
0 |
4 |
|a 610
|q DE-101
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.81
|2 bkl
|
| 100 |
1 |
|
|a Aichelin, Katharina
|e VerfasserIn
|0 (DE-588)1211128326
|0 (DE-627)1698984766
|4 aut
|
| 245 |
1 |
0 |
|a Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
|c presented by M.Sc. (Biotechnology) Katharina Deborah Aichelin ; Referees: Prof. Dr. Peter Angel [und ein weiterer Gutachter]
|
| 264 |
|
1 |
|a Heidelberg
|c 2017
|
| 300 |
|
|
|a XII, 108 Seiten
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 502 |
|
|
|b Dissertation
|c Ruperto-Carola University of Heidelberg
|d 2017
|
| 546 |
|
|
|a Text Englisch, Zusammenfassung in deutscher und englischer Sprache
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f DISS
|x XA-DE-BW
|2 pdager
|5 DE-16
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Angel, Peter
|e AkademischeR BetreuerIn
|0 (DE-588)1080056572
|0 (DE-627)843623179
|0 (DE-576)453297668
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 776 |
0 |
8 |
|i Erscheint auch als
|n Online-Ausgabe
|a Aichelin, Katharina
|t Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
|d Heidelberg, 2020
|h 1 Online-Ressource (XII, 108 Seiten)
|w (DE-627)1698983379
|
| 936 |
b |
k |
|a 44.38
|j Pharmakologie
|q SEPA
|0 (DE-627)106409743
|
| 936 |
b |
k |
|a 44.81
|j Onkologie
|q SEPA
|0 (DE-627)106409433
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20200730
|
| 993 |
|
|
|a Thesis
|
| 998 |
|
|
|g 1211128326
|a Aichelin, Katharina
|m 1211128326:Aichelin, Katharina
|d 140000
|d 140001
|e 140000PA1211128326
|e 140001PA1211128326
|k 0/140000/
|k 1/140000/140001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN172557974X
|e 3732861481
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"recId":"172557974X","person":[{"display":"Aichelin, Katharina","given":"Katharina","role":"aut","family":"Aichelin"},{"family":"Angel","role":"dgs","display":"Angel, Peter","given":"Peter"}],"name":{"displayForm":["presented by M.Sc. (Biotechnology) Katharina Deborah Aichelin ; Referees: Prof. Dr. Peter Angel [und ein weiterer Gutachter]"]},"language":["eng"],"noteThesis":["Dissertation. - Ruperto-Carola University of Heidelberg. - 2017"],"origin":[{"publisherPlace":"Heidelberg","dateIssuedKey":"2017","dateIssuedDisp":"2017"}],"corporate":[{"display":"Universität Heidelberg","role":"dgg"}],"type":{"bibl":"thesis"},"title":[{"title_sort":"Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma","title":"Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma"}],"id":{"eki":["172557974X"]},"physDesc":[{"extent":"XII, 108 Seiten","noteIll":"Illustrationen, Diagramme"}]}
|
| SRT |
|
|
|a AICHELINKADEVELOPMEN2017
|
